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A Sabin 1 strain poliovirus (PV) mutant, S1(2Y-1I), carrying a Tyr at amino acid position VP2142 and an Ile at position VP1160,
can establish persistent infections in HEp-2c cells. This mutant forms atypical 147S particles upon interaction at 0°C with
either cells expressing PV receptor (PVR) CD155, or PVR-IgG2a, a chimeric molecule consisting of an extracellular moiety of
PVR and the hinge and Fc portion of a mouse IgG2a. Upon interaction with PVR at 37°C, S1(2Y-1I), similar to the parental
strain, forms both 135S A particles and 80S empty capsids. At 0°C, surprisingly, at a concentration equal to or greater than
5 nM, PVR-IgG2a induced both the extrusion of VP4 from the capsid of S1(2Y-1I) and the formation of 80S particles. The same
transitions were observed at 0°C with the parental strain Sabin 1 at 40 nM PVR-IgG2a. Thus, the formation of 80S particles
and VP4 extrusion, considered as one of the steps of PV uncoating, can be temperature-independent at high PVR© 2002 Elsevier Science (USA)
INTRODUCTION
Poliovirus (PV), the causative agent of poliomyelitis, is
the prototype member of the Picornaviridae family. The
virion consists of a small single-strand positive-sense
RNA enclosed in a nonenveloped icosahedral capsid
made up of 60 copies of each of the four structural
proteins, VP1 to VP4. The three-dimensional structure of
the viral particle has been elucidated by crystallographic
studies (Hogle et al., 1985). The capsid consists of 12
pentamers, each composed of five protomers, and the
virion thus has a total of 60 PV receptor (PVR)-binding
sites (Arita et al., 1998; Belnap et al., 2000; He et al.,
2000). PVR (CD155) is a member of the immunoglobulin
superfamily and its natural functions are unknown (Koike
et al., 1990; Mendelsohn et al., 1989), although it has
recently been shown specifically to bind vitronectin
(Lange et al., 2001) by the extracellular domains, and
Tctex-1, a light chain of the dynein motor complex, by the
cytoplasmic domain (Mueller et al., 2002; Ohka and No-
moto, 2001). The first step of infection starts with the
binding of PV to PVR on the surface of susceptible cells.
This adsorption step can occur in vitro at 0°C. Dove and
Racaniello reported results suggesting that the PV cap-
sid must undergo structural changes to bind to PVR
(Dove and Racaniello, 2000). At temperatures higher than
32°C, the PVR induces changes in viral conformation,
which modify the sedimentation coefficient of the virionfrom 160S to generate A particles, at 135S, and empty
capsids, at 80S (Flore et al., 1990; Fricks and Hogle,
1990). There has been some question about the role of
135S A particles in infection, because the efficiency of A
particle-mediated infection is low and A particles do not
accumulate when virus is grown at 26°C (Curry et al.,
1996; Dove and Racaniello, 1997). Recently, it has been
shown that the efficiency of infection of A particles can
be increased; production of A particles is rate limiting at
26°C and therefore they would not be expected to accu-
mulate (Huang et al., 2000). Both A particles and empty
capsids have lost VP4, but only the latter has lost the viral
genome. Therefore, it is generally believed that the for-
mation of 80S empty capsids results from viral uncoating.
PVR-IgG2a (or CD155-IgG2a), a chimeric molecule con-
sisting of an extracellular moiety of PVR and the hinge
and Fc portion of a mouse IgG2a, together with Fc re-
ceptor-expressing cells, were used to confirm the impor-
tance of specific PV-PVR interactions in viral uncoating
(Arita et al., 1999). It has also been shown that PVR acts
as a catalyst, increasing the rate of capsid transitions by
lowering the activation barrier (Tsang et al., 2001).
In studies of PV persistence in HEp-2c cells, we dem-
onstrated the accumulation of an atypical particle, sedi-
menting at 147  3 S, upon adsorption of a type 3 PV
(PV3) mutant onto PVR-expressing cells at 0°C (Duncan
et al., 1998). The 147S particle was not produced as a
result of inherent capsid instability and was generated
only upon specific PV–host cell interactions (Duncan andconcentration. This implies that structural changes of the
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tence were identified, mapping to amino acid residues
VP1160 (Val3 Ile) (1I) and VP2142 (His3 Tyr) (2Y) (Pelletier
et al., 1998a). One (2Y) is in the E-F loop of VP2, in the
canyon, and directly interacts with the PVR (Belnap et al.,
2000; He et al., 2000). The other is in  strand E, near the
E-F loop, at the interface between protomers, near resi-
dues of the PVR-binding site and above the hydrophobic
pocket which is believed to contain a sphingosine mol-
ecule in the mature virion (Belnap et al., 2000; Colston
and Racaniello, 1995; Filman et al., 1989; He et al., 2000).
This determinant may alter the plasticity of the viral
capsid of persistent mutants. The 1I and 2Y mutations
independently modify the adsorption, elution, and un-
coating transitions of the mutants, but no 147S forms
have been detected following interaction of these single-
point mutants with PVR (Pelletier et al., 1998a). To inves-
tigate further the uncoating process of persistent mu-
tants, we studied PVR-induced transitions of the corre-
sponding double mutant S1(2Y-1I) after interaction with
either PVR-expressing cells or soluble PVR-IgG2a. Sur-
prisingly, at some PVR-IgG2a concentrations, the soluble
receptor alone was capable of producing 147S and 80S
particles at 0°C. The extrusion of VP4 from the capsid
indicated that the structure of the PV capsid changed
following adsorption at low temperature.
RESULTS
PV receptor-induced conformational changes after
adsorption onto HEp-2c cells
To determine the cumulative effect of the two determi-
nants 1I and 2Y on receptor-induced conformational
changes, we studied the kinetics of transition from the
160S to the 135S A particles for the S1(2Y-1I) double
mutant. Radiolabeled virions were prepared in HEp-2c
cells with [35S]methionine and purified as previously de-
scribed (Pelletier et al., 1998b). HEp-2c cell infections
were synchronized by a 2.5-h period of adsorption at
0°C, and then conformational transitions were started by
incubation at 37°C for 3 or 10 min. Cell-associated viral
particles were separated by centrifugation in sucrose
gradients (15–30% w/v) as described (Pelletier et al.,
1998b). The sedimentation profile of the parental virus S1
showed, as expected, one peak corresponding to the
160S virions. This peak decreased upon incubation at
37°C, and a peak of 135S A particles appeared concom-
itantly (Fig. 1, top). In contrast, the sedimentation profile
of the S1(2Y-1I) mutant was atypical. At the end of the
adsorption period at 0°C, there was a peak correspond-
ing to the 147S particles previously observed for the PV-3
mutants (Duncan and Colbe`re-Garapin, 1999; Duncan et
al., 1998). Incubation at 37°C caused a decrease of the
147S peak, with a simultaneous shift to a position corre-
sponding to the 135S A particles, suggesting that the
147S particles underwent a conformational transition to
A particles (Fig. 1, bottom). As expected, these A particles
were unstable in cells: the peak of cell-associated par-
ticles decreased substantially upon incubation of cells at
37°C. When the fraction corresponding to the top of the
147S peak was analyzed again in a 15–30% sucrose
gradient, only half of the remaining radioactivity was
found associated with particles still sedimenting at 147S
(data not shown). This suggests that the 147S particles of
S1(2Y-1I) are unstable. The conformational transition to
135S A particles at 37°C was complete for the S1(2Y-1I)
mutant but only partial for S1 (Fig. 1, bottom). This sug-
gests that the flexibility of the capsid and viral uncoating
were enhanced by the S1(2Y-1I) mutations.
FIG. 1. PVR-induced conformational transition on HEp-2c cells of
the parental Sabin 1 virus and of the S1(2Y-1I) persistent mutant.
Cells were incubated with [35S]methionine-labeled viruses for 2.5 h
at 0°C, and for 0, 3, or 10 min at 37°C, washed, and lysed as
described (Pelletier et al., 1998a). Cell lysates were subjected to
centrifugation in 15–30% sucrose gradients. Empty capsids were
used as markers in parallel gradients.
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Characterization of 147S particles
We first analyzed the protein composition of 147S
particles to determine whether or not they contained
VP4. The 147S particles were obtained by incubating
HEp-2c cells with radiolabeled S1(2Y-1I) for 2.5 h at 0°C.
After sedimentation in sucrose gradients, an aliquot of
each fraction was counted to verify the profile of the peak
(Fig. 2A). Then, fractions (8 to 15) including most of the
147S particles were analyzed by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) in par-
allel to virions of 160S and eluted A particles of 135S for
both the S1 and the S1(2Y-1I) viruses. The radioactivity of
each of the four capsid protein bands was quantified
using a STORM 820 apparatus (Molecular Dynamics). As
expected, the VP4 protein was detected in the 160S
particles and not in the A particles of both the S1 strain
and the S1(2Y-1I) mutant (Fig. 2B). The VP4 protein was
present in each of the eight fractions of the peak corre-
sponding to the 147S particles of the S1(2Y-1I) mutant
(Fig. 2B), and the proportions of each of the four capsid
proteins were similar for the 147S particles and the
control 160S particles (Fig. 2C).
We determined the density of 147S particles by CsCl
gradient centrifugation. The cells were incubated with
the radiolabeled S1 and S1(2Y-1I) virions for 2.5 h at 0°C,
and then half of each sample was analyzed in sucrose
gradients and the other half in CsCl gradients (Fig. 3).
The interaction between the PVR and the S1(2Y-1I) mu-
tant induced the expected modification of the sedimen-
tation coefficient of the particle (147S), but the density
was similar for both 147S and 160S particles, strongly
suggesting that the low sedimentation coefficient (147S)
of the S1(2Y-1I) particles was not a result of the loss of
the viral genome. This was confirmed by testing the
infectivity of 147S particles (data not shown).
Interactions of viruses with the chimeric receptor
PVR-IgG2a
To see whether the 147S particle is induced by the
specific virus–receptor interaction alone, without any
contribution from other cellular factors, we studied the
transition kinetics of S1 and S1(2Y-1I) using PVR-IgG2a.
35S-labeled virions (2 1010 particles) were incubated for
2.5 h at 0°C with various concentrations of PVR-IgG2a (0
to 20 nM, in a volume of 200 l) and the sedimentation
profiles in sucrose gradients were determined (Figs. 4A
and 4B).
The parental virus S1 appeared to form a peak sedi-
menting at the 160S position when the PVR-IgG2a con-
centration was less than or equal to 5 nM (Fig. 3B).
Surprisingly, at higher PVR-IgG2a concentrations (10 or
20 nM), the peak was shifted toward the top of the
gradient, near the 147S position (Fig. 4B, left-hand pan-
els). Thus, the parental strain S1 seemed to form 147S
particles in these cell-free conditions, although they have
never been observed upon adsorption onto cells.
We verified that S1(2Y-1I) sedimented at 160S similar
to S1, after incubation for 2.5 h at 0°C in the absence of
PVR-IgG2a (Fig. 4A). Even at the lowest PVR-IgG2a con-
centration (1.25 nM) at 0°C, the peak of S1(2Y-1I) parti-
cles was shifted to the 147S position. This receptor
concentration corresponds to 0.125 molecules per bind-
ing site and 7.5 molecules per virion, which would be the
equivalent of 15 PVR domains per virion, assuming both
heads of the chimera can bind, but these numbers are
likely to be upper estimates for the actual occupancy.
When a concentration of 5 nM PVR-IgG2a (i.e., 0.5 mol-
ecules per binding site) was used with S1(2Y-1I), this
peak was again slightly shifted toward the top of the
gradient, at 135S, and surprisingly, a peak at the 80S
position of empty capsids appeared (Fig. 4B, right-hand
panels). In addition, at even higher PVR-IgG2a concen-
trations (20 nM, i.e., two molecules per binding site), the
transition of S1(2Y-1I) to 80S particles was almost com-
plete. Although such sedimentation profiles are normal
at 37°C where uncoating occurs, it was unexpected
under these experimental conditions, i.e., at 0°C. These
results suggested that uncoating could occur at 0°C in
the presence of high concentrations of PVR-IgG2a. We
tested whether this phenomenon was observed with the
S1 strain at a very high PVR-IgG2a concentration (40 nM,
i.e., four molecules per binding site). The 80S peak was
observed (Fig. 4C), but the PVR-IgG2a concentration re-
quired to obtain a sedimentation profile similar to that of
S1(2Y-1I) was eightfold higher in the case of S1 (Figs. 4B
and 4C).
When the adsorption period at 0°C was followed by an
incubation of 7 min at 37°C, soluble PVR-IgG2a, similar
to PVR-expressing cells, induced uncoating transitions
(Fig. 4D). S1 transitions were almost complete at PVR-
IgG2a concentrations of 5 nM or above (Fig. 4D). For
S1(2Y-1I) at 37°C, the transition kinetics were similar for
all PVR-IgG2a concentrations and the transition was in
all cases more efficient than that observed for the S1
strain (Fig. 4D). These findings agree with those obtained
with HEp-2c cells (Fig. 1).
Digestion of the 147S particles with V8 protease
As 147S and 160S particles seem to only differ by their
sedimentation coefficient but not their composition, we
looked for externalization of the N-terminus of VP1, as
observed during the transition from 160S virions to A
particles at 37°C (Fricks and Hogle, 1990). We studied
the susceptibility of the 147S particles to the Glu-c V8
endoproteinase. The first four Glu residues of VP1 in A
particles are accessible to this protease, such that it
generates four digestion fragments (Curry et al., 1996).
The concentrations of PVR-IgG2a which induced transi-
tions similar to those obtained after interaction of the
57POLIOVIRUS/CD155-IgG2a INTERACTIONS
FIG. 2. Protein analysis of 147S particles. [35S]methionine-labeled S1(2Y-1I) mutant was incubated with HEp-2c cells for 2.5 h at 0°C and cells were
lysed. Cell lysates were fractionated in sucrose gradients. (A) The 35S radioactivity of an aliquot of each fraction was counted. (B)The fractions (8–15)
corresponding to the 147S peak were analyzed by 14% SDS–PAGE. The 160S and 135S A particles from S1 and S1(2Y-1I) were used as markers. VP1
protein from strain S1 and from the S1(2Y-1I) mutant migrated between VP2 and VP3 as previously reported (Pelletier et al., 1991). (C) Radioactivity
of each of the four capsid proteins was quantified using a STORM 820 apparatus (Molecular Dynamics) and is expressed as a percentage of the total
radioactivity with the Image Quant software.
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viruses with HEp-2c cells were chosen (5 and 1.25 nM).
Radiolabeled viruses were incubated for 2.5 h at 0°C
with (or without) PVR-IgG2a, then incubated for 7 min at
0°C or 37°C. An aliquot of each sample was layered onto
sucrose gradients to verify the position of the peaks. In
parallel, samples were exposed to various concentra-
tions (0, 5, or 10 g per ml) of V8 for 1 h at 4°C. As
expected, 135S A particles from both S1 and S1(2Y-1I)
viruses were digested by the enzyme: the VP1 protein
migrated as a smear between the VP2 and VP3 proteins
which remained intact (Fig. 5). VP1 proteins in 160S
particles used as controls were not digested. The 147S
particles from the S1(2Y-1I) mutant seemed to be resis-
tant to V8 digestion, suggesting that the N-terminus of
the VP1 protein was not externalized during the 160S to
147S conversion at 0°C. Therefore, 147S particles have
several properties in common with 160S particles. A
modification of the sedimentation coefficient of atypical
particles could be due to either a modification of the
conformation of the particle, such as an expansion, or an
attachment of PVR-IgG2a molecules, or both.
Are 147S particles saturated with hPVR-IgG2a
molecules?
To address the possibility that the 147S particles could
be the result of an excess of bound PVR-IgG2a, we
quantified this molecule in the gradient by slot blot assay,
as described under Materials and Methods. In parallel to
S1 and S1(2Y-1I), Coxsackievirus B1 (CVB1), which does
not interact with PVR, was used as a negative control. No
chimeric receptor cosedimented with CVB1 (Fig. 6). For
all three viruses, the majority of PVR-IgG2a molecules
were located at the same position between fractions 30
and 35 (Fig. 6). A small number of PVR-IgG2a molecules
cosedimented with the 147S particles of S1 and S1(2Y-1I)
(Fig. 6). The total number of (bound and free) PVR-IgG2a
molecules present in the fractions of peaks was calcu-
lated. There was an average of about three PVR-IgG2a
molecules per viral particle for the 160S particles of S1,
nine for the 147S particles of S1, and three for the 147S
particles of S1(2Y-1I). Therefore, these particles were far
from being saturated with receptor and similar amounts
of receptor cosedimented with S1 160S virions and
S1(2Y-1I) 147S particles. However, the possibility that the
attachment of a few PVR-IgG2a molecules contributed to
delaying the sedimentation of 147S particles was not
excluded.
PVR-IgG2a-mediated VP4 extrusion from particles
at 0°C
The PVR-IgG2a-mediated formation of 135S and 80S
particles at 0°C was unexpected. We therefore looked for
the presence of VP4 in the various particles by SDS–
PAGE (Table 1). The particles obtained after incubation of
S1 with 5 nM PVR-IgG2a at 0°C were at the 160S position
and contained the VP4 protein, as expected. When this
adsorption period was followed by 7 min incubation at
37°C, the particles sedimented at 135S and did not
contain VP4 and therefore appeared to be A particles. S1
particles sedimenting at 147S and 135S positions after
interaction with the receptor at 0°C still contained VP4.
This indicates that these 135S particles differed from A
particles. In contrast, VP4 was not detected in S1 80S
particles which formed at 0°C and 40 nM PVR-IgG2a
(Table 1).
Similar results were obtained with the S1(2Y-1I) mutant
but at lower concentrations of PVR-IgG2a (Table 1). At
0°C and 1.25 nM PVR-IgG2a, 147S particles formed, still
containing VP4. After incubation at 37°C, A and 80S
particles formed, both having lost VP4, even at the lowest
FIG. 3. Determination of the density of S1(2Y-1I) 147S particles in CsCl gradients. Cells were incubated with radiolabeled S1 or S1(2Y-1I) virions
for 2.5 h at 0°C, and half of each sample was analyzed in a sucrose gradient (left-hand panel) and half in a CsCl gradient (right-hand panel).
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concentration of PVR-IgG2a. Particles formed at 0°C and
20 nM PVR-IgG2a and sedimenting at 135S still con-
tained VP4, but the 80S particles which formed simulta-
neously did not contain VP4 (Table 1).
DISCUSSION
Similar to some type 3 persistent PV mutants (Duncan
and Colbe`re-Garapin, 1999; Duncan et al., 1998), the type
FIG. 4. Analysis in sucrose gradients (15–30%) of transitions of S1 and S1(2Y-1I) viruses with various concentrations of PVR-IgG2a in a cell-free
system. Radiolabeled S1 and S1(2Y-1I) viruses were incubated for 2.5 h at 0°C. (A) Without PVR-IgG2a or (B) with PVR-IgG2a at various concentrations
(1.25 to 20 nM). (C) An additional high concentration of PVR-IgG2a (40 nM) was used with the S1 virus. (D) Viruses were incubated with PVR-IgG2a
at various concentrations (1.25 to 20 nM) for 2.5 h at 0°C, then for 7 min at 37°C.
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1 persistent mutant S1(2Y-1I) was able to form 147S
particles following virus adsorption onto HEp-2c cells at
0°C. However, unlike the type 3 mutants, these particles
were efficiently converted into A particles upon incuba-
tion at 37°C, suggesting that the 147S particle may be an
intermediate in the formation of A particles, and possibly
in the uncoating process of this mutant (Fig. 1). This
conversion was complete for the mutant in 10 min,
whereas it was only partial for S1, suggesting that the
mutations in S1(2Y-1I) facilitated the conformational tran-
sitions of the capsid. The VP4 protein was present in
147S particles, in the same proportion as in the native
virion, indicating that the modification of the sedimenta-
tion coefficient of viral particles following adsorption onto
cells at 0°C was not due to a change in the protein
composition. Consistent with the presence of the viral
genome in 147S particles, these particles had the same
density as virions as assessed by CsCl density gradient
ultracentrifugation and were infectious (data not shown).
147S particles were similarly formed with soluble chi-
meric PVR-IgG2a molecules and with PVR-expressing
cells and are thus specifically induced by the PVR. They
were resistant to V8 protease digestion, suggesting that
the N-terminus of VP1 in 147S particles is not external-
ized.
Remarkably, high PVR-IgG2a concentrations induced
the formation of 80S particles and VP4 extrusion at 0°C
with both virus strains. The simultaneous presence of the
two mutations of S1(2Y-1I) facilitated the required transi-
tions, at 0°C similar to at 37°C. The transition of S1(2Y-1I)
to 80S particles at 0°C was almost complete for as few
as two PVR-IgG2a molecules per binding site. Even at
low temperature, it is thus probable that the mutations
increased capsid flexibility, thereby lowering the energy
activation barrier of the reaction catalyzed by PVR. The
formation of 80S particles implies that conformational
transitions of the capsid occurred. Therefore, the pro-
gressive shift of VP4-containing particles toward the top
of the gradient, at 147S and up to 135S, may correspond
to progressive conformational transitions of the capsid.
However, it is possible that the binding of some PVR-
IgG2a molecules to viral particles contributed to delay
their sedimentation, as proposed in the case of human
rhinovirus 3 upon interaction with its receptor, ICAM-1, at
34°C (Casasnovas and Springer, 1994; Greve et al., 1991;
Hoover-Litty and Greve, 1993).
At the cell surface, the binding of the virion to PVR may
recruit further adjacent PVR molecules (Racaniello,
1996). Possibly, PVR induces a progressive conforma-
tional change in the capsid forming several successive
transient intermediates as observed with increasing
PVR-IgG2a concentration. Constrained multivalent re-
ceptor attachment, applied by the linkage to the Fc frag-
ment in the chimeric receptor, or by the cell membrane,
may facilitate the formation of 80S particles and RNA
release. The transition intermediates may be unstable,
particularly at 37°C. The presence of the PVR as clusters
on cells (Mannweiler et al., 1990) may favor the confor-
mational changes of the capsid. This is consistent with
the broad 147S peak observed with the mutant after
adsorption onto cells at 0°C: several particle conforma-
tions may be present simultaneously at the cell surface.
In conclusion, the formation of 80S particles, which is
considered to be one of the final steps of PV uncoating,
can be temperature-independent at high PVR-IgG2a con-
centration. The persistent PV mutants display highly
modified PV-PVR interactions and are precious tools for
investigating the early steps of PV infection.
MATERIALS AND METHODS
Cells, viruses, and recombinant PVR
HEp-2c cells were grown in Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 10% newborn calf se-
rum (NCS). We used the PV Sabin 1 strain LSc 2ab (S1)
(Sabin and Boulger, 1973) and the mutant virus S1(2Y-1I)
FIG. 5. Susceptibility of 147S particles to V8 protease. Radiolabeled S1 and S1(2Y-1I) viruses were incubated for 2.5 h at 0°C with or without
PVR-IgG2a and then incubated or not incubated for 7 min at 37°C. An aliquot of each sample was layered onto a sucrose gradient to verify the position
of the peak. The samples were exposed to digestion by various concentrations (0, 5, and 10 g/ml) of V8 for 1 h at 4°C, and then analyzed by 12.5%
SDS–PAGE as described under Materials and Methods.
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(Pelletier et al., 1998a) carrying two amino acid substitu-
tions selected during persistent infection of human neu-
roblastoma IMR-32 cells. S1 viral stocks were prepared
on HEp-2c cells and those of S1(2Y-1I) on IMR-32 cells
(to maintain the selective pressure for the mutations).
Infectivity was titered by an endpoint micromethod on
HEp-2c cells in 96-well plates. The infectious titers are
expressed as infectious doses 50 (ID50) per milliliter and
correspond to the log10 of the highest virus dilution for
which cytopathic effects and cell lysis were observed in
50% of wells 7 days after infection.
PVR-IgG2a is a chimeric molecule in which the extra-
cellular moiety of human PVR is joined to the hinge and
Fc region of a mouse IgG2a molecule (Arita et al., 1999).
Crude PVR-IgG2a was prepared from culture superna-
tants of recombinant baculovirus-infected Sf9 cells and
purified on a protein A-Sepharose 4B column (Pharmacia
Biotech) as described (Arita et al., 1999). The concentra-
FIG. 6. Detection of PVR-IgG2a cosedimenting with viral particles in sucrose gradients. Radiolabeled S1, CVB1, and S1(2Y-1I) viruses were incubated
with the indicated PVR-IgG2a concentration for 2.5 h at 0°C and samples were analyzed in sucrose gradients (15–30%). The 147S particles of S1 and
S1(2Y-1I) were obtained with 20 and 1.25 nM PVR-IgG2a, respectively. The radioactivity in an aliquot of each fraction was counted, and another aliquot
was used in a slot blot assay to detect PVR-IgG2a with an anti-mouse IgG Fc fragment conjugated with peroxidase (see Materials and Methods).
PVR-IgG2a was quantified with a MultiImager, using a range of known concentrations of PVR-IgG2a for reference.
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tion of PVR-IgG2a, considered as a dimer similar to an
IgG, was determined by measuring the absorbance at
280 nm. PVR-IgG2a was stored at 80°C in phosphate-
buffered saline (PBS) (10 mM phosphate buffer pH 7, 137
mM NaCl, and 2.6 mM KCl) supplemented with 1% bo-
vine serum albumin (BSA).
Preparation of purified radiolabeled virions
Radiolabeled virions were prepared in HEp-2c cells
with [35S]methionine (1400 Ci/mmol; ICN) and purified by
CsCl density gradient centrifugation as previously de-
scribed (Blondel et al., 1983; Pelletier et al., 1991). The
specific activities of S1 and S1(2Y-1I) varied between
104 and 5  104 cpm/ID50.
For experiments with PVR-IgG2a, radiolabeled virions
were prepared as recommended by Arita and colleagues
(Arita et al., 1998). Briefly, HEp-2c cells in monolayer
culture (2  107 cells) were infected with PV at an m.o.i.
of 10 ID50/cell. Two and one-half hours postinfection, the
medium was changed to methionine- and cysteine-free
medium containing 4 mCi [35S]methionine and [35S]cys-
teine (TRAN35S-LABEL; ICN). Cells were collected 7 h
postinfection and virus was purified from cytoplasmic
extracts of the infected cells on sucrose gradient (15–
30% w/v) and then by CsCl density gradient centrifuga-
tion as previously described (Blondel et al., 1983; Pelle-
tier et al., 1998a). Purified virus was desalted by gel
filtration on a PD-10 column (Pharmacia Biotech) equili-
brated with PBS and then stored at 80°C. The concen-
tration of virus was determined by measuring absor-
bance at 260 nm, with 1.0 optical density unit being
considered to be equivalent to 9.4  1012 viral particles
(Rueckert, 1976). Under these conditions, the specific
activities of S1, S1(2Y-1I), and CVB1 were between 0.7
and 1.5  105 cpm/viral particle.
Analysis of PVR-induced transitions in sucrose
gradients
HEp-2c cells in suspension (107 cells) were infected
with 35S-methionine-labeled virions at a m.o.i. of 50 ID50/
cell in 2 ml DMEM-2% fetal calf serum (FCS) on ice for
2.5 h. Cells were then washed twice in DMEM-FCS on
ice. Conformational alterations were started by the ad-
dition of 3 ml DMEM-FCS preheated to 37°C and cells
were incubated for various times (0, 3, and 10 min) at
37°C. Cells were then washed successively with ice-
cold DMEM-FCS and PBS. Cell pellets were resus-
pended in 500 l of 140 mM NaCl, 50mM Tris–HCl pH 8,
1% Nonidet P-40, 0.1% SDS and incubated on ice for 20
min (cell lysis step). Samples were centrifuged for 5 min
at 10,000 rpm at 4°C and the supernatant was layered
onto 15 to 30% (w/v) sucrose gradients prepared in PBS.
Gradients were centrifuged in a Kontron TST41.14 rotor
for 2 h at 40,000 rpm at 4°C and fractionated. The amount
of 35S-label of all or a part of each fraction was counted
in scintillation vials.
For experiments with PVR-IgG2a, microtubes were first
coated overnight with BSA, using a 1% BSA solution in
PBS (PBS-BSA). Radiolabeled virions (2  1010 particles)
were incubated for 2.5 h at 0°C in 200 l PBS-BSA in the
presence of various concentrations of PVR-IgG2a (0 to 40
nM). Then, the samples were incubated for 0 or 7 min at
37°C, treated with 1% NP-40 and 0.1% SDS, as in the cell
lysis step, and layered onto 15 to 30% (w/v) sucrose
gradients as described above.
Virions (160S) and 80S particles, purified by CsCl gra-
dient centrifugation, and eluted 135S particles (see be-
low), were layered onto parallel sucrose gradients and
used as sedimentation markers.
Preparation of eluted 135S particles
To obtain eluted 135S particles, HEp-2c cells in sus-
pension (5  107 cells) were first infected with radiola-
beled S1 or S1(2Y-1I) virus at an m.o.i. of 50 ID50/cell in 5
ml DMEM-FCS on ice for 2.5 h. Cells were then washed
twice in DMEM-FCS on ice. Alterations were started by
the addition of 800 l DMEM-FCS preheated to 37°C and
allowed to continue for 15 min at 37°C. Cells were then
pelleted by centrifugation for 5 min at 1000 rpm at 4°C,
and the supernatants containing eluted A particles were
layered onto sucrose gradients, which were centrifuged
and fractionated as described above.
TABLE 1
Presence of the VP4 Protein in the Particles Separated in Sucrose
Gradient after Incubation of S1 or S1(2Y-1I) with PVR-IgG2a at Various
Concentrations
Virusa
PVR-IgG2a
(nM)
Incubation
at 37°Cb
Peak
analyzedc
Presence
of VP4d
S1 5  160S 
5  135S 
20  147S 
40  135S 
40  80S 
S1 (2Y-1I) 1.25  147S 
1.25  135S 
20  135S 
20  80S 
a Radiolabeled virus (2  1010 particles) was incubated for 2.5 h at
0°C with PVR-IgG2a.
b  and  indicate incubation for 7 min at 37°C or no incubation
after adsorption.
c The position of peaks was determined in sucrose gradient (15–
30%). S1 160S, 135S A, and 80S particles were used as markers in
parallel gradients.
d Fractions corresponding to the top of the peak were analyzed by
SDS–PAGE. Radioactivity associated with each of the four capsid pro-
teins was quantified using a STORM 820 (see Materials and Methods)
and is expressed as a percentage of the total radioactivity. The pres-
ence of VP4 is noted  when the percentage of radioactivity corre-
sponding to VP4 was greater than 2.5% and  when it was 0%.
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Analysis of viral proteins by polyacrylamide gel
electrophoresis
Fractions from sucrose gradients were incubated for 6
min at 90°C in the presence of 1% SDS and loaded onto
0.1% SDS–14% polyacrylamide gels for electrophoresis
(SDS–PAGE). Purified radiolabeled S1 and S1(2Y-1I) viri-
ons and the corresponding eluted 135S particles were
analyzed on sucrose gradients. The two or three frac-
tions containing the majority of the 160S and 135S par-
ticles were used as 160S and 135S markers, respectively.
After SDS–PAGE, the radioactivity of each of the four
capsid protein bands was quantified using a STORM 820
apparatus (Molecular Dynamics) and is expressed as a
percentage of the total radioactivity with the Image
Quant software.
V8 protease digestion
Radiolabeled S1 and S1(2Y-1I) (2 1010 particles) were
incubated for 2.5 h at 0°C in 200 l of PBS-BSA with, or
without, PVR-IgG2a (at concentrations of 1.25 and 5 
109 M, respectively; see Results). Then, samples were
incubated for 0 or 7 min at 37°C. Aliquots of 10 l of
these samples in PBS were treated with various V8
protease concentrations (0, 5, and 10 g/ml) for 1 h at
4°C in a final volume of 100 l. Samples were then
analyzed by 0.1%SDS–12.5% PAGE, as described above.
Quantification of PVR-IgG2a in sucrose gradients.
Radiolabeled S1, S1(2Y-1I), and CVB1 viruses were
incubated with PVR-IgG2a (at the indicated concentra-
tion) for 2.5 h at 0°C and samples were analyzed in
sucrose gradients (15–30%) as described above. The
radioactivity in 50 l of each fraction was counted, and
100 l was used in a slot blot assay to detect PVR-IgG2a
with an anti-mouse IgG Fc fragment conjugated with
peroxidase (Sigma). The bound peroxidase activity was
revealed with the ECL Plus Western blotting detection
system (Amersham Pharmacia Biotech, U.K.) and quan-
tified with a MultiImager Fluor-S and the Quantity one
software (Bio-Rad), using a range of known concentra-
tions of PVR-IgG2a. Then, in the three fractions corre-
sponding to the top of peaks, the number of PVR-IgG2a
molecules per radiolabeled particle was calculated
based on the number of cpm and the specific activity of
the radiolabeled virus.
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